Abstract
Introduction: Incidence of antibiotic- associated diarrhoea is a common (10–30%) but pseudomembranous colitis (PMC) is less frequent (1-5%). Fluoroquinolones, clindamycin, penicillins, cephalosporins (mostly third generation) are commonly associated with PMC. The association between cephalosporins and PMC is now well established.
Case Presentation: A 78 year old male patient developed pseudomembraneous colitis after administration of Ceftriaxone and Cefazoline for the treatment of pleural effusion. The reaction was confirmed by ultrasonography and CT scan. Causative agents were stopped and patient was managed by systemic therapy. Patient was expired due to respiratory complications as there was complexity in management of disease due to development of pseudomembraneous colitis.
Conclusion: Increase awareness of prescribers for high-risk drugs, close monitoring, with immediate withdrawal of the culprit drug can reduce the complexity of management that occur due to development of such adverse drug reaction.
Keywords: Pseudomembraneous colitis, cephalosporins, clostidium difficile, ceftriaxone, cefazoline, MSCT.
Current Drug Safety
Title:Cephalosporins Associated Pseudomembraneous Colitis in an Elderly Male Patient - A Case Report
Volume: 12 Issue: 3
Author(s): Prashant M. Parmar, Vipul V. Solanki, Manish J. Barvaliya, Bhavesh C. Chavada and Chandrabhanu Rajkishor Tripathi*
Affiliation:
- CM 31/13, Shantinagar 2, Near Bhagwati Circle, Kalvibid, Bhavnagar-364002, Gujarat,India
Keywords: Pseudomembraneous colitis, cephalosporins, clostidium difficile, ceftriaxone, cefazoline, MSCT.
Abstract: Introduction: Incidence of antibiotic- associated diarrhoea is a common (10–30%) but pseudomembranous colitis (PMC) is less frequent (1-5%). Fluoroquinolones, clindamycin, penicillins, cephalosporins (mostly third generation) are commonly associated with PMC. The association between cephalosporins and PMC is now well established.
Case Presentation: A 78 year old male patient developed pseudomembraneous colitis after administration of Ceftriaxone and Cefazoline for the treatment of pleural effusion. The reaction was confirmed by ultrasonography and CT scan. Causative agents were stopped and patient was managed by systemic therapy. Patient was expired due to respiratory complications as there was complexity in management of disease due to development of pseudomembraneous colitis.
Conclusion: Increase awareness of prescribers for high-risk drugs, close monitoring, with immediate withdrawal of the culprit drug can reduce the complexity of management that occur due to development of such adverse drug reaction.
Export Options
About this article
Cite this article as:
Parmar M. Prashant , Solanki V. Vipul , Barvaliya J. Manish , Chavada C. Bhavesh and Tripathi Rajkishor Chandrabhanu *, Cephalosporins Associated Pseudomembraneous Colitis in an Elderly Male Patient - A Case Report, Current Drug Safety 2017; 12 (3) . https://dx.doi.org/10.2174/1574886312666170616091217
DOI https://dx.doi.org/10.2174/1574886312666170616091217 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment
Current Pharmaceutical Design Convulsions with Gastroenteritis: Reflections on some Cases and Tentative Diagnostic Score
Current Pediatric Reviews Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases
Current Drug Targets Cranial Ultrasound - Optimizing Utility in the NICU
Current Pediatric Reviews Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
Current Medicinal Chemistry Therapeutic Application of Melatonin in the Treatment of Melanoma: A Review
Current Cancer Therapy Reviews Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design Long-Term CD4 Cell Count Recovery among Thai Naive HIV-Infected Patients Initiating HAART at Low CD4 Cell Count
Current HIV Research Intracranial Non-traumatic Aneurysms in Children and Adolescents
Current Pediatric Reviews PEGylated Liposomal Vancomycin: A Glimmer of Hope for Improving Treatment Outcomes in MRSA Pneumonia
Recent Patents on Anti-Infective Drug Discovery Crosstalk between Inflammation and the BBB in Stroke
Current Neuropharmacology Desferrioxamine as Immunomodulatory Agent During Microorganism Infection
Current Pharmaceutical Design Non-viral Gene Delivery and Therapeutics Targeting to Brain
Current Nanoscience Isolation of the Antibacterial Agent Viridiol from the Mangrove Endophytic Fungus Hypocrea virens, as Monitored by a Biologic Assay Against Escherichia coli and NMR Spectroscopy
Current Biotechnology Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Immunomodulatory Effect of Phytoactive Compounds on Human Health: A Narrative Review Integrated with Bioinformatics Approach
Current Topics in Medicinal Chemistry West Nile Virus NS2B/NS3 Protease As An Antiviral Target
Current Medicinal Chemistry Global Epidemiology, Clinical Features, Diagnosis and Current Therapeutic Novelties in Migraine Therapy and their Prevention: A Narrative Review
Current Pharmaceutical Design Deciphering Tuberculous Meningitis: From Clinical Challenges to Novel Models and Pathogenic Pathways
Current Topics in Medicinal Chemistry Emerging Promise of Phytochemicals in Ameliorating Neurological Disorders
CNS & Neurological Disorders - Drug Targets